Roth reiterates a Buy rating and $67 target on Cree (NASDAQ:CREE).
The firm cites checks at the ICSCRM event, which show the Delphi partnership including a $500M+ SiC MOSFETS purchase order from a European auto OEM.
Cree's total revenues were $251.2M last quarter.
Cree shares are up 2.5% pre-market to $50.22.
Subscribe for full text news in your inbox